scholarly journals Impact of a Novel Emergency Department Forward Treatment Area During the New York City COVID-19 Surge

2021 ◽  
Vol 22 (4) ◽  
pp. 871-877
Author(s):  
Joshua Moskovitz ◽  
Kaushal Khambhati ◽  
Comilla Sasson ◽  
Jason D’Amore ◽  
Michael Jones ◽  
...  
Keyword(s):  
Emergency Department ◽  
New York ◽  
New York City ◽  
York City ◽  
Treatment Area ◽  
Hospital System ◽  
Number Of Patients ◽  
Lower Oxygen ◽  
Disproportionate Number ◽  
Public Hospital System

Introduction: Coronavirus disease 2019 (COVID-19) caused a disproportionate number of patients to seek emergency care at hospitals in New York City (NYC) during the initial crisis. Our urban emergency department (ED), a member of the NYC public hospital system had to process the increased volume while also differentiating our patients’ critical needs. We established a forward treatment area (FTA) directly in front of the ED to accomplish these goals from March 23–April 16, 2020. Methods: A clinical greeter evaluated patients 18 years and older who presented to the walk-in entrance of the ED where they were screened for COVID-19-like complaints. If they did not appear critically ill and could ambulate they were directed into the FTA. Clinical and non-clinical staff worked in concert to register, evaluate, and process patients with either a disposition of directly home or into the ED for further care. Results: A total of 634 patients were seen in the FTA from March 23–April 16, 2020. Of the 634 patients evaluated, 135 (21%) were referred into the ED for further evaluation, of whom 81 (12.7% of the total) were admitted. These patients were disproportionately male (91 into the ED and 63 admitted) and tended to have a higher heart rate (105.4 vs 93.7), a higher respiratory rate (21.5 vs 18.1), and lower oxygen saturation (93.9% vs 97.8%). Conclusion: A forward treatment area is an effective method to rapidly screen and process an increased volume of COVID-19 patients when resources are limited. This treatment area helped decompress the ED by being rapidly deployable and effectively screening patients for safe discharge home.

scholarly journals Pesticide Spraying for West Nile Virus Control and Emergency Department Asthma Visits in New York City, 2000

2004 ◽  
Vol 112 (11) ◽  
pp. 1183-1187 ◽  
Author(s):  
Adam M. Karpati ◽  
Mary C. Perrin ◽  
Tom Matte ◽  
Jessica Leighton ◽  
Joel Schwartz ◽  
...  
Keyword(s):  
Emergency Department ◽  
New York ◽  
New York City ◽  
West Nile Virus ◽  
York City ◽  
West Nile ◽  
Virus Control

scholarly journals Gender differences in HIV risk behaviors in an adult emergency department in New York City

1999 ◽  
Vol 76 (2) ◽  
pp. 237-246 ◽  
Author(s):  
Jonathan Shuter ◽  
Peter L. Alpert ◽  
Max G. DeShaw ◽  
Barbara Greenberg ◽  
Chee Jen Chang ◽  
...  
Keyword(s):  
Gender Differences ◽  
Emergency Department ◽  
New York ◽  
New York City ◽  
Risk Behaviors ◽  
Hiv Risk ◽  
York City ◽  
Hiv Risk Behaviors

scholarly journals Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City

2021 ◽  
Author(s):  
Demetra Tsapepas ◽  
S Ali Husain ◽  
Kristen L King ◽  
Yvonne Burgos ◽  
David J Cohen ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
York City ◽  
Vulnerable Population ◽  
Pancreas Transplant ◽  
Vaccine Hesitancy ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Number Of Patients ◽  
Outreach Initiative

Abstract Purpose Solid organ transplant recipients are at increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19), but limited vaccine access and vaccine hesitancy can complicate efforts for expanded vaccination. We report patient perspectives and outcomes from a vaccine outreach initiative for a vulnerable population of transplant recipients living in New York City. Methods This was a retrospective review of qualitative perspectives from a COVID-19 vaccine outreach initiative. In the outreach effort, kidney and pancreas transplant recipients under care at the transplant center at NewYork-Presbyterian Hospital were initially contacted electronically with educational material about vaccination followed by telephone outreach to eligible unvaccinated patients. Calls were used to schedule vaccine appointments for patients who agreed, answer questions, and assess attitudes and concerns for patients not yet ready to be vaccinated, with conversational themes recorded. Results Of the 1,078 patients living in the 5 New York City boroughs who had not reported receiving COVID-19 vaccination, 320 eligible patients were contacted by telephone. Of these, 210 patients were scheduled for vaccination at our vaccine site (including 13 who agreed to vaccination after initially declining), while 110 patients were either not ready or not interested in being vaccinated. The total number of patients willing to be vaccinated was 554 when also including those already vaccinated. Unwillingness to be vaccinated was associated with younger age (median age of 47 vs 60 years, P < 0.001), Black race (P = 0.004), and residence in Bronx or Brooklyn counties (P = 0.018) or a zip code with a medium level of poverty (P = 0.044). The most common issues raised by patients who were ambivalent or not interested in vaccination were regarding unknown safety of the vaccines in general, a belief that there was a lack of data about the vaccines in transplant recipients, and a lack of trust in the scientific process underlying vaccine development, with 34% of the patients contacted expressing vaccine hesitancy overall. Conclusion Our qualitative summary identifies determinants of COVID-19 vaccine hesitancy in a diverse transplant patient population, supporting the need for transplant centers to implement tailored interventions to increase vaccine acceptance in this vulnerable population.

Sign in / Sign up

Export Citation Format

Share Document